Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, David Flowers et al.|Blood|1999Cited by 456
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, Frederick R. Appelbaum et al.|Blood|1999Cited by 439